AN OPEN-LABEL, NEOADJUVANT PHASE 2 CLINICAL TRIAL COMPARING THE EFFECTS OF AR INHIBITION WITH AND WITHOUT SRC OR MEK INHIBITION ON THE DEVELOPMENT OF EMT IN PROSTATE CANCER: AN OUTCOME REPORT
JOURNAL OF UROLOGY（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined